Siemens Healthcare: service element is vital addition to product offering
This article was originally published in Clinica
Executive Summary
Having spent Euro11.2bn ($17.5bn) over the last 18 months in buying three major IVDs groups, Siemens Healthcare has managed to gain a broad oversight into the trends and pressures within the global diagnostics sector - in vivo and in vitro.